JAMES KANE: Open Payments
NPI 1568100998 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 44 payments from 15 companies in 2025. Trend: 2023 $1,576 · 2024 $1,740 · 2025 $1,348
Food & beverage: $951Education: $397
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $499 |
| Janssen Biotech, Inc. | 8 | $159 |
| Dendreon Pharmaceuticals LLC | 1 | $146 |
| ABBVIE INC. | 6 | $128 |
| Antares Pharma, Inc. | 4 | $105 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| ACCORD HEALTHCARE, INC. | 3 | $61 |
| Endo USA, Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: Xtandi, ERLEADA, PROVENGE, XYOSTED, BOTOX, Camcevi, GEMTESA, ORGOVYX.
Industry payments across CA — which companies pay providers there.
